{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Education Life Supplement", "lead_paragraph": "Lena Kagan, the first female dean of Harvard Law School, had an epiphany in the women's bathroom at a conference hall in Cambridge, Mass., last year. There, neatly stacked in a basket, was a supply of free tampons. ''It's such a small thing, but it says a lot about whether a place cares about its women,'' she says. A few months later, every women's room at Harvard Law had a supply. Change is taking many forms these days at the nation's professional schools. Business students network at potluck dinners. Medical schools incorporate more materials on women's health. At law schools, the Socratic method has come under attack, its dominance diluted by approaches thought to be more woman-friendly. The changes reflect the schools' responses to increased numbers of female students.", "headline": {"main": "Beyond 'Sweetie'"}, "abstract": "Yilu Zhao article on how nation's law, business and medical schools are changing in ways that reflect increased numbers of female students; photo (special section, Education Life) (L)", "print_page": "20", "word_count": 2954, "_id": "4fd259fd8eb7c8105d806768", "snippet": "Women's place in professional schools: more is merrier.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/07/education/edlife/117GEN.html", "multimedia": [{"url": "images/2004/11/07/education/edlife/07women.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2004/11/07/education/edlife/07women.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "BUSINESS SCHOOLS"}, {"name": "subject", "value": "LAW SCHOOLS"}, {"name": "subject", "value": "MEDICAL SCHOOLS"}, {"name": "subject", "value": "COLLEGES AND UNIVERSITIES"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "SPECIAL SECTIONS"}, {"name": "subject", "value": "LEGAL PROFESSION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Yilu", "rank": 1, "lastname": "Zhao"}], "original": "By Yilu Zhao"}, "document_type": "article", "pub_date": "2004-11-07T00:00:00Z", "section_name": "Health; Education; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Amid intense criticism that it is slow to raise the alarm about unsafe medicines, the Food and Drug Administration announced Friday that it would hire the nation's top scientific review body to figure out whether the drug safety system is adequate. In another step, after embarrassing disclosures that the views of its own drug safety officials had been suppressed, the F.D.A. said it would set up an internal appeals process. If someone inside the agency feels that superiors have made a mistake by approving a drug or, after approval, refusing to order its recall, that person will be able to make a case before a committee of experts, from inside and outside the agency, who were not involved in the decision.", "headline": {"main": "F.D.A.'s Drug Safety System Will Get Outside Review"}, "abstract": "Food and Drug Administration will hire Institute of Medicine to study how well agency assesses dangers of unexpected side effects of marketed drugs; institute is part of National Academy of Sciences, government's top scientific reviewer; FDA, after disclosures that views of its own drug safety officials had been suppressed, says it will also set up internal appeals process (M)", "print_page": "11", "word_count": 939, "_id": "4fd2497e8eb7c8105d7e6be6", "snippet": "The Food and Drug Administration announced it would hire the government's top scientific review agency to figure out whether its drug-safety system is adequate.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/06/politics/06fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "INSTITUTE OF MEDICINE"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "NATIONAL ACADEMY OF SCIENCES"}, {"name": "subject", "value": "ACCIDENTS AND SAFETY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2004-11-06T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Insurance and pharmaceutical executives said Thursday that they were pleased and immensely relieved at the election results. President Bush's victory, they said, guarantees that the new Medicare prescription drug program will be carried out by officials who enthusiastically support it. By contrast, they said, if John Kerry had won the election, he would have tried to revise and repeal major parts of the law, and the appointment of a new team of federal health officials would have delayed efforts to carry out the complex measure.", "headline": {"main": "Insurers and Drug Makers See Gain in Bush Victory"}, "abstract": "Insurance and pharmaceutical executives said Thursday say they are immensely relieved at Pres Bush's re-election because administration is committed to success of new Medicare drug program; Democrat John Kerry denounced new law as doing more to help companies than the elderly (M)", "print_page": "26", "word_count": 785, "_id": "4fd241468eb7c8105d7d932f", "snippet": "President Bush's victory guarantees that the new Medicare prescription drug program will be carried out by officials who enthusiastically support it.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/05/politics/campaign/05health.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "KERRY, JOHN"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2004"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2004-11-05T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "The threat, not well understood outside the medical community, has been rendered with authoritative starkness since news broke of the flu vaccine shortage. Lives are at risk. Every year, we are told, influenza kills multitudes of vulnerable people, and the death toll is often repeated: 36,000 die annually in the United States alone. The lethal efficiency of the flu has come as a surprise to many, it turns out, because almost no one is ever officially classified as dying of influenza.", "headline": {"main": "The Flu Kills, But Documents Rarely List It As the Killer"}, "abstract": "Tracking number of annual deaths from influenza is difficult in New York City, where death certificates rarely attribute official causes of death to flu and generally cite pneumonia; by some estimations, 2,500 deaths in 2002 were caused by influenza, but only two were listed as resulting from flu (M)", "print_page": "1", "word_count": 1087, "_id": "4fd25a638eb7c8105d806c73", "snippet": "Death certificates rarely list influenza as a cause of death, which makes national accounting of flu deaths difficult.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/03/nyregion/03flu.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "organizations", "value": "CENTERS FOR DISEASE CONTROL AND PREVENTION"}, {"name": "subject", "value": "INFLUENZA"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "EMPHYSEMA"}, {"name": "subject", "value": "VIRUSES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "PNEUMONIA"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Marc", "rank": 1, "lastname": "SANTORA"}], "original": "By MARC SANTORA"}, "document_type": "article", "pub_date": "2004-11-03T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "There's an unfortunate twist associated with this season's shortage of flu vaccine. Now that many people who could be protected cannot be immunized, everyone seems to want the vaccine against this costly, debilitating and sometimes life-threatening viral illness. Perhaps next year people will remember this desire to protect themselves against the flu when, we hope, there will be enough vaccine available to meet the demand.", "headline": {"main": "No Vaccines? You Can Still Fight the Flu", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody Personal Health column discusses recent shortage of flu vaccine and gives ways to prevent getting flu, including rigorous hand washing and boosting immune system through healthy life style; suggests some medications and supplements that may reduce severity of flu; drawing (M)", "print_page": "6", "word_count": 1237, "_id": "4fd259fb8eb7c8105d8066d6", "snippet": "People should avoid contracting the flu \u0097 not just for their own well-being but also for the well-being of those they live, work and socialize with.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/02/health/02brod.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "PERSONAL HEALTH (TIMES COLUMN)"}, {"name": "subject", "value": "HANDS"}, {"name": "subject", "value": "LIFE STYLES"}, {"name": "subject", "value": "INFLUENZA"}, {"name": "subject", "value": "DIETARY SUPPLEMENTS AND HERBAL REMEDIES"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "SANITATION"}, {"name": "subject", "value": "SHORTAGES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "IMMUNE SYSTEM"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2004-11-02T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The agency that runs the Medicare program said Monday that it was creating a demonstration project in which cancer doctors will be paid to measure how their patients feel during chemotherapy. In another of a series of relatively small steps involving cancer treatment, the agency, the Centers for Medicare and Medicaid Services, proposed paying for a variety of colon cancer drugs when those medications are used in any of nine clinical trials that will test their effectiveness against other cancers.", "headline": {"main": "Medicare Takes Steps Broadening Coverage of Cancer Care"}, "abstract": "Agency that runs Medicare program will set up $300-million nationwide demonstration project in which oncologists will be paid $130 per patient per day to collect data on how patients feel during chemotherapy; project reflects Admr Mark B McClellan's response to doctors' complaints about lower reimbursements by giving them additional money, in exchange for getting more data; Medicare will also pay for certain drugs for colon cancer, but only as part of clinical trials (M)", "print_page": "18", "word_count": 589, "_id": "4fd2808f8eb7c8105d84b85c", "snippet": "The agency said that it was creating a project in which cancer doctors will be paid to measure how their patients feel during chemotherapy.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/02/politics/02drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MCCLELLAN, MARK B"}, {"name": "organizations", "value": "MEDICARE"}, {"name": "subject", "value": "COLON"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "CHEMOTHERAPY"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2004-11-02T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 6, "offset": 0, "time": 21}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}